Cargando…

A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma

BACKGROUND: Circulating long noncoding RNAs (lncRNAs) have been demonstrated to serve as diagnostic biomarkers for various cancers. We aimed to elucidate the diagnostic efficacy of eight serum lncRNAs HULC, MALAT1, Linc00152, PTENP1, PTTG3P, SPRY4-IT1, UBE2CP3, and UCA1 and their combinations for th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Jinlan, Zheng, Yansong, Xiao, Xialin, Liu, Can, Lin, Jinpiao, Zheng, Sijia, Yang, Bin, Ou, Qishui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376401/ https://www.ncbi.nlm.nih.gov/pubmed/32733618 http://dx.doi.org/10.1155/2020/5417598

Ejemplares similares

Serum Cyr61 is Associated With Clinical Disease Activity and Inflammation in Patients With Systemic Lupus Erythematosus
por: Lin, Jinpiao, et al.
Publicado: (2015)

Compartmentalisation of Hepatitis B virus X gene evolution in hepatocellular carcinoma microenvironment and the genotype-phenotype correlation of tumorigenicity in HBV-related patients with hepatocellular carcinoma
por: Fu, Ya, et al.
Publicado: (2022)

Circulating MicroRNA Panel as a Diagnostic Marker for Hepatocellular Carcinoma
por: Wu, Xiaochang, et al.
Publicado: (2022)

Datasets of YY1 expression in rheumatoid arthritis patients
por: Lin, Jinpiao, et al.
Publicado: (2016)

The combination of circulating long noncoding RNAs AK001058, INHBA-AS1, MIR4435-2HG, and CEBPA-AS1 fragments in plasma serve as diagnostic markers for gastric cancer
por: Ke, Dong, et al.
Publicado: (2017)

The High Expression of Adhering and Circulating Integrin Serves as a Diagnostic Marker in Venous Thromboembolism
por: Yang, Fan, et al.
Publicado: (2022)

Long Noncoding RNAs Serve as Potential Diagnostic Biomarkers for Colorectal Cancer
por: Cai, Juan, et al.
Publicado: (2019)

iTRAQ‐based proteomic analysis of differentially expressed proteins in sera of seronegative and seropositive rheumatoid arthritis patients
por: He, Yujue, et al.
Publicado: (2021)

Circulating Adipokines and Hepatokines Serve as Diagnostic Markers during Obesity Therapy
por: Schmid, Andreas, et al.
Publicado: (2022)

Circulating Long and Circular Noncoding RNA as Non-Invasive Diagnostic Tools of Hepatocellular Carcinoma
por: Sukowati, Caecilia H. C., et al.
Publicado: (2021)

YY1 regulation by miR-124-3p promotes Th17 cell pathogenicity through interaction with T-bet in rheumatoid arthritis
por: Lin, Jinpiao, et al.
Publicado: (2021)

Taurocholic acid inhibits the response to interferon-α therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8(+) T and NK cell function
por: Xun, Zhen, et al.
Publicado: (2021)

Establishment of Real Time Allele Specific Locked Nucleic Acid Quantitative PCR for Detection of HBV YIDD (ATT) Mutation and Evaluation of Its Application
por: Zeng, Yongbin, et al.
Publicado: (2014)

Anti-ferroptotic PRKAA2 serves as a potential diagnostic and prognostic marker for hepatoblastoma
por: Xie, Yi, et al.
Publicado: (2023)

Early detection of hepatocellular carcinoma via liquid biopsy: panel of small extracellular vesicle‐derived long noncoding RNAs identified as markers
por: Kim, Soon Sun, et al.
Publicado: (2021)

Long noncoding RNA GIHCG functions as an oncogene and serves as a serum diagnostic biomarker for cervical cancer
por: Zhang, Xiaolian, et al.
Publicado: (2019)

CCN1 Promotes Inflammation by Inducing IL-6 Production via α6β1/PI3K/Akt/NF-κB Pathway in Autoimmune Hepatitis
por: Jiang, Renquan, et al.
Publicado: (2022)

Long noncoding RNA LINC02418 regulates MELK expression by acting as a ceRNA and may serve as a diagnostic marker for colorectal cancer
por: Zhao, Yinghui, et al.
Publicado: (2019)

Emerging roles of bile acids in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma
por: Xun, Zhen, et al.
Publicado: (2023)

Long Noncoding RNA PTTG3P Expression Is an Unfavorable Prognostic Marker for Patients With Hepatocellular Carcinoma
por: Bai, Hansong, et al.
Publicado: (2019)

Circulating microRNA-200 Family as Diagnostic Marker in Hepatocellular Carcinoma
por: Dhayat, Sameer A., et al.
Publicado: (2015)

Circulating microRNAs Serve as Novel Biological Markers for Intracranial Aneurysms
por: Li, Pengxiang, et al.
Publicado: (2014)

Exosomes serve as tumour markers for personalized diagnostics owing to their important role in cancer metastasis
por: An, Taixue, et al.
Publicado: (2015)

Combination of plasma HA and circulating M2-like monocytes may serve as a diagnostic marker for breast cancer
por: Zhang, Boke, et al.
Publicado: (2017)

GOLPH2 expression may serve as diagnostic marker in seminomas
por: Fritzsche, Florian R, et al.
Publicado: (2010)

Serum epidermal growth factor-like domain 7 serves as a novel diagnostic marker for early hepatocellular carcinoma
por: Yang, Meng-Yuan, et al.
Publicado: (2021)

Senescence marker protein 30 (SMP30) serves as a potential prognostic indicator in hepatocellular carcinoma
por: Mo, Zhijing, et al.
Publicado: (2016)

Circulating microRNA-122a as a diagnostic marker for hepatocellular carcinoma
por: Luo, Jie, et al.
Publicado: (2013)

IFIT3 Is Increased in Serum from Patients with Chronic Hepatitis B Virus (HBV) Infection and Promotes the Anti-HBV Effect of Interferon Alpha via JAK-STAT2 In Vitro
por: Xu, Siyi, et al.
Publicado: (2022)

Long non-coding RNA HULC as a diagnostic and prognostic marker of pancreatic cancer
por: Ou, Zheng-Lin, et al.
Publicado: (2019)

circRNA_104075 stimulates YAP-dependent tumorigenesis through the regulation of HNF4a and may serve as a diagnostic marker in hepatocellular carcinoma
por: Zhang, Xiao, et al.
Publicado: (2018)

FIMICS: A panel of long noncoding RNAs for cardiovascular conditions()
por: Firat, Huseyin, et al.
Publicado: (2023)

RPNs Levels Are Prognostic and Diagnostic Markers for Hepatocellular Carcinoma
por: Zheng, Wangyang, et al.
Publicado: (2022)

CD69 serves as a potential diagnostic and prognostic biomarker for hepatocellular carcinoma
por: Tang, Kaihua, et al.
Publicado: (2023)

Circulating Long Noncoding RNAs Act as Diagnostic Biomarkers in Non-Small Cell Lung Cancer
por: Yuan, Shuai, et al.
Publicado: (2020)

Two Novel Long Noncoding RNAs – RP11-296E3.2 and LEF1-AS1can – Separately Serve as Diagnostic and Prognostic Bio-Markers of Metastasis in Colorectal Cancer
por: Shi, Qian, et al.
Publicado: (2019)

The effects of genetic polymorphisms of APOE on circulating lipid levels in middle-aged and elderly chinese Fujian Han population: toward age- and sex-personalized management
por: Liu, Xiaofeng, et al.
Publicado: (2021)

Long Noncoding RNA SNHG7 Is a Diagnostic and Prognostic Marker for Colon Adenocarcinoma
por: Jiang, Chengwei, et al.
Publicado: (2022)

A distinctively expressed long noncoding RNA, RP11‐466I1.1, may serve as a prognostic biomarker in hepatocellular carcinoma
por: Zhang, Junyong, et al.
Publicado: (2018)

Diagnostic value of long noncoding RNAs for hepatocellular carcinoma: A PRISMA-compliant meta-analysis
por: Hao, Qing-Qin, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_qou610d11dpmrs3lij0jarjlno